Does enzyme replacement therapy enhance brain-derived neurotrophic factor expression in Gaucher disease?

J Neuroimmunol

Department of Infectious Diseases and Clinical Microbiology, Agri Military Hospital, Agri, Turkey.

Published: February 2015

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2015.01.003DOI Listing

Publication Analysis

Top Keywords

enzyme replacement
4
replacement therapy
4
therapy enhance
4
enhance brain-derived
4
brain-derived neurotrophic
4
neurotrophic factor
4
factor expression
4
expression gaucher
4
gaucher disease?
4
enzyme
1

Similar Publications

Nanobodies (Nbs) hold great potential to replace conventional antibodies in various biomedical applications. However, conventional methods for their discovery can be time-consuming and expensive. We have developed a reliable protein selection strategy that combines magnetic activated cell sorting (MACS)-based screening of yeast surface display (YSD) libraries and functional ligand-binding identification by Tat-based recognition of associating proteins (FLI-TRAP) to isolate antigen-specific Nbs from synthetic libraries.

View Article and Find Full Text PDF

A novel polysaccharide in the envelope of influences the septal secretion of preproteins with a YSIRK/GXXS motif.

J Bacteriol

January 2025

Department of Microbiology, Howard Taylor Ricketts Laboratory, The University of Chicago, Chicago, Illinois, USA.

Unlabelled: Bacteria transport proteins across the plasma membrane to assemble their envelope, acquire nutrients, and establish appropriate interactions with their environment. The majority of these proteins are synthesized as precursors with a cleavable N-terminal signal sequence for recognition by the Sec machinery. In , a small subset of secreted precursors carries a YSIRK/GXXS motif.

View Article and Find Full Text PDF

Characterization of the oxygen-tolerant formate dehydrogenase from .

Front Microbiol

January 2025

Department of Plant Physiology, Institute of Biosciences, University of Rostock, Rostock, Germany.

Fixation of CO into the organic compound formate by formate dehydrogenases (FDHs) is regarded as the oldest autotrophic process on Earth. It has been proposed that an FDH-dependent CO fixation module could support CO assimilation even in photoautotrophic organisms. In the present study, we characterized FDH from (FDH) due to its ability to reduce CO under aerobic conditions.

View Article and Find Full Text PDF

Dental manifestations of hypophosphatasia: translational and clinical advances.

JBMR Plus

February 2025

Division of Biosciences, College of Dentistry, The Ohio State University, Columbus, OH, 43210, United States.

Hypophosphatasia (HPP) is an inherited error in metabolism resulting from loss-of-function variants in the gene, which encodes tissue-nonspecific alkaline phosphatase (TNAP). TNAP plays a crucial role in biomineralization of bones and teeth, in part by reducing levels of inorganic pyrophosphate (PP), an inhibitor of biomineralization. HPP onset in childhood contributes to rickets, including growth plate defects and impaired growth.

View Article and Find Full Text PDF

Summary: Hypophosphatasia (HPP) is a genetic disorder due to pathological variants in ALPL, the gene encoding tissue-nonspecific alkaline phosphatase (ALP). HPP is typically associated with bone-related symptoms, such as bone deformity, fractures and bone pain in children, but can appear in adults with symptoms resembling arthritis. A 22-year-old male experienced repeated and severe sudden attacks of joint pain in the elbows and knees.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!